Correlation Between Postoperative Cognitive Dysfunction and Telomere Length in Patients With Non-cardiac Surgery
1 other identifier
observational
1,000
1 country
1
Brief Summary
To study on the Postoperative Cognitive Dysfunction: Correlations With Leukocyte telomere length。
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 27, 2018
CompletedFirst Posted
Study publicly available on registry
October 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedOctober 12, 2018
October 1, 2018
4.4 years
September 27, 2018
October 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
the neuropsychological test to measure cognitive function
1 day before surgery(baseline)
Mini-Mental score examination [MMSE] used for screening of dementia
1 day before surgery(baseline)
the leukocyte telomere length
on the surgery day
the neuropsychological test to measure cognitive function
within the first 7 days (plus or minus 2 days) after surgery
Mini-Mental score examination [MMSE] used for screening of dementia
within the first 7 days (plus or minus 2 days) after surgery
the neuropsychological test to measure cognitive function
within the first 3 months (plus or minus 1 month) after surgery
Mini-Mental score examination [MMSE] used for screening of dementia
within the first 3 months (plus or minus 1 month) after surgery
the neuropsychological test to measure cognitive function
within the first 1 year (plus or minus 3 months) after surgery
Mini-Mental score examination [MMSE] used for screening of dementia
within the first 1 year (plus or minus 3 months) after surgery
the neuropsychological test to measure cognitive function
within the first 3 years (plus or minus 1 year) after surgery
Mini-Mental score examination [MMSE] used for screening of dementia
within the first 3 years (plus or minus 1 year) after surgery
Study Arms (2)
study group
1000 Male and female patients undergoing non-cardiac surgery at the Affiliated Hospital of Xuzhou Medical University \[Jiangsu China\]. We do the neuropsychological tests, Mini-Mental score examination (MMSE) and olfaction test 1 day before (baseline) and 1 week,3 months,1 year and 3 years after surgery without safety issue.We also measure their preoperative leukocyte telomere length.
control group
We enroll 50 healthy volunteers and do the neuropsychological tests, Mini-Mental score examination (MMSE) and olfaction test at 1 day (baseline), 1 week, 3 months, 1 year and 3 years without safety issue.
Interventions
We do the neuropsychological tests, Mini-Mental score examination (MMSE) and olfaction test 1 day before (baseline) and 1 week,3 months,1 year and 3 years after surgery without safety issue.
Eligibility Criteria
We included 1000 Male and female patients undergoing non-cardiac surgery and 50 healthy volunteers at the affiliated hospital of Xuzhou Medical University.
You may qualify if:
- Non-cardiac surgery patients;
- Age is greater than or equal to 65 years old;
- Han Nationality, mother tongue is chinese;
- ④The MMSE score:Illiteracy is greater than or equal to 17 points, primary school is greater than or equal to 20 points, higher secondary school is more than 24 points;
- ⑤The Geriatric Depression Scale (GDS) grade 1 or 2;
- ⑥The important function without serious heart, brain, liver, kidney, lung and other organs;
- The ASA class I or II;
- The people signed informed consent.
You may not qualify if:
- The diagnosis of neurological and psychiatric disorders, such as Alzheimer's disease, Parkinson's syndrome, multiple sclerosis, schizophrenia, depression, etc.; ②Had severe head and face disease, trauma history or history of surgery;
- Had a history of influenza in 3 weeks; ④The serious body disease and tobacco, wine and other substance abuse history; ⑤The presence of malignant tumor with shorter survival disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesia of the Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor-in-charge of Anesthetist
Study Record Dates
First Submitted
September 27, 2018
First Posted
October 12, 2018
Study Start
August 1, 2016
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
October 12, 2018
Record last verified: 2018-10